Loading...
A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms
Myeloproliferative neoplasms are a varied group of disorders that can have prolonged chronic phases, but eventually accelerate and can transform into a secondary acute myeloid leukemia that is ultimately fatal. Triapine is a novel inhibitor of the M2 subunit of ribonucleotide reductase. Sequential i...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ferrata Storti Foundation
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3971077/ https://ncbi.nlm.nih.gov/pubmed/24362550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.097246 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|